GlassScriptPhysician profile
Daniel Richard Calnan
NPI 1710397492
$3,795.75
in general payments reported to CMS, 2019-2025
9 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,913 · 2022: $338 · 2023: $267 · 2024: $547 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,544.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,912.64 | 2021 | |
| Imperative Care, INC | $1,304.51 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom 88 Large Distal Platform Support |
| Medtronic, INC. | $265.91 | 2024 | Pipeline, Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Penumbra, INC. | $99.11 | 2022-2025 | Red 72 |
| Route 92 Medical, INC. | $70.28 | 2025 | |
| Microvention, INC. | $67.02 | 2024-2025 | Web Aneurysm Embolization System, Lvis Junior, Stent |
| Orthofix Medical, INC. | $30.30 | 2022-2023 | Spinal-Stim, Spinal-Stim |
| Inspiremd LTD | $24.98 | 2025 | Cguard Prime Carotid Stent System |
| Stryker Corporation | $21.00 | 2025 | Trevo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Calnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.